bristol_myers_squibb (product)

literal strings: Bristol-Myers Squibb, Bristol-myers squibb, Bristol Myers Squibb, BRISTOL MYERS SQUIBB, BRISTOL-MYERS SQUIBB, Bristol-Myers-Squibb, Bristol Myers-Squibb, bristol myers squibb, Bristol-myers Squibb

categories

NELL has only weak evidence for items listed in grey

• drug
• SEAL @132 (50.0%) on 23-jul-2010 [ 1 ] using bristol_myers_squibb
• product
• SEAL @56 (50.0%) on 21-feb-2010 [ 1 ] using bristol_myers_squibb

relations

NELL has only weak evidence for items listed in grey

• agentworkedondrug
• buspirone
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (buspirone, bristol_myers_squibb)
• OE @808 (100.0%) on 29-jan-2014 [   ] using (buspirone, bristol_myers_squibb)
• capoten
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg2 under the trade name arg1" "arg2 under the brand names arg1" "arg2 under the brand name arg1" ] using (capoten, bristol_myers_squibb)
• carboplatin
• OE @820 (92.4%) on 06-mar-2014 [   ] using (carboplatin, bristol_myers_squibb)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (carboplatin, bristol_myers_squibb)
• didanosine
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (didanosine, bristol_myers_squibb)
• OE @973 (100.0%) on 23-jan-2016 [ http://www.jstor.org/stable/4456949 http://www.bms.com/products/Pages/trademark.aspx http://www.bms.com/products/Pages/trademark.aspx  ] using (didanosine, bristol_myers_squibb)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (didanosine, bristol_myers_squibb)
• entecavir
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (entecavir, bristol_myers_squibb)
• fosinopril
• OE @809 (94.9%) on 01-feb-2014 [   ] using (fosinopril, bristol_myers_squibb)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (fosinopril, bristol_myers_squibb)
• gatifloxacin
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (gatifloxacin, bristol_myers_squibb)
• OE @823 (94.0%) on 17-mar-2014 [   ] using (gatifloxacin, bristol_myers_squibb)
• hydroxyurea
• OE @803 (100.0%) on 13-jan-2014 [   ] using (hydroxyurea, bristol_myers_squibb)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (hydroxyurea, bristol_myers_squibb)
• irbesartan
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (irbesartan, bristol_myers_squibb)
• ixempra
• SEAL @545 (75.0%) on 02-apr-2012 [ 1 2 ] using (ixempra, bristol_myers_squibb)
• metformin
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (metformin, bristol_myers_squibb)
• nefazodone
• OE @799 (100.0%) on 25-dec-2013 [ http://www.rxlist.com/serzone-drug/indications-dosage.htm http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=4449 http://www.drugbank.ca/drugs/DB01149 http://en.wikipedia.org/wiki/Nefazodone http://bjp.rcpsych.org/content/180/6/528.full http://depression.emedtv.com/nefazodone/nefazodone-p5.html  ] using (nefazodone, bristol_myers_squibb)
• SEAL @623 (100.0%) on 10-aug-2012 [ 1 2 ] using (nefazodone, bristol_myers_squibb)
• paraplatin
• OE @1080 (100.0%) on 30-nov-2017 [ https://www.ncbi.nlm.nih.gov/pubmed/15561808 http://onlinelibrary.wiley.com/doi/10.1111/j.1365-4632.2004.02112.x/abstract https://www.ncbi.nlm.nih.gov/pubmed/16249353 http://www.sagentpharma.com/wpcproduct/carboplatin-injection/  ] using (paraplatin, bristol_myers_squibb)
• SEAL @224 (87.5%) on 24-mar-2011 [ 1 2 3 ] using (paraplatin, bristol_myers_squibb)
• plavix
• SEAL @241 (100.0%) on 22-apr-2011 [ 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ] using (plavix, bristol_myers_squibb)
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" "arg1 is marketed by arg2" ] using (plavix, bristol_myers_squibb)
• OE @892 (100.0%) on 26-dec-2014 [ http://www.medicalnewstoday.com/articles/247925.php  ] using (plavix, bristol_myers_squibb)
• reyataz
• SEAL @221 (96.9%) on 18-mar-2011 [ 1 2 3 4 5 ] using (reyataz, bristol_myers_squibb)
• serzone
• CPL @1094 (93.8%) on 01-jan-2018 [ "arg2 has voluntarily withdrawn arg1" "arg2 is not recalling arg1" "arg2 voluntarily pulled arg1" "arg2 and marketed under the name arg1" ] using (serzone, bristol_myers_squibb)
• OE @1015 (97.4%) on 09-sep-2016 [ http://www.rxlist.com/serzone-drug/medication-guide.htm http://toxic-torts.lawyers.com/toxic-torts/serzone-lawsuits.html http://www.serzone-antidepressant-drug.com/ http://injury.findlaw.com/product-liability/serzone.html http://www.yourlawyer.com/topics/overview/serzone http://en.wikipedia.org/wiki/Nefazodone http://injury.findlaw.com/product-liability/serzone.html http://www.ahrp.org/infomail/04/05/19.php  ] using (serzone, bristol_myers_squibb)
• SEAL @241 (75.0%) on 22-apr-2011 [ 1 2 ] using (serzone, bristol_myers_squibb)
• sprycel
• SEAL @269 (98.4%) on 24-may-2011 [ 1 2 3 4 5 6 ] using (sprycel, bristol_myers_squibb)
• OE @961 (97.0%) on 24-nov-2015 [ http://www.cancer.gov/cancertopics/druginfo/fda-dasatinib http://www.bmspaf.org/ http://news.bms.com/press-release/rd-news/four-year-data-phase-3-dasision-trial-comparing-sprycel-dasatinib-imatinib-fir http://news.bms.com/press-release/rd-news/fda-approves-us-product-labeling-update-sprycel-dasatinib-include-three-year-f http://abcnews.go.com/blogs/extras/2013/12/18/bristol-myers-squibb-responds-to-abc-news/ http://news.bms.com/press-release/rd-news/four-year-data-phase-3-dasision-trial-comparing-sprycel-dasatinib-imatinib-fir http://news.bms.com/press-release/rd-news/fda-approves-us-product-labeling-update-sprycel-dasatinib-include-three-year-f http://www.bmscanada.ca/en/products/sprycel  ] using (sprycel, bristol_myers_squibb)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 was discovered and developed by arg2" ] using (sprycel, bristol_myers_squibb)
• sustiva
• SEAL @221 (75.0%) on 18-mar-2011 [ 1 2 ] using (sustiva, bristol_myers_squibb)
• CPL @1094 (87.5%) on 01-jan-2018 [ "arg1 marketed by arg2" "arg1 It is manufactured by arg2" "arg1 is manufactured by arg2" ] using (sustiva, bristol_myers_squibb)
• taxol
• SEAL @224 (96.9%) on 24-mar-2011 [ 1 2 3 4 5 ] using (taxol, bristol_myers_squibb)
• CPL @1094 (50.0%) on 01-jan-2018 [ "arg1 is manufactured by arg2" ] using (taxol, bristol_myers_squibb)
• tequin
• SEAL @241 (100.0%) on 22-apr-2011 [ 1 ] using (tequin, bristol_myers_squibb)
• OE @809 (85.1%) on 01-feb-2014 [   ] using (tequin, bristol_myers_squibb)
• videx
• SEAL @562 (93.8%) on 07-may-2012 [ 1 2 3 4 ] using (videx, bristol_myers_squibb)
• zerit
• CPL @1094 (75.0%) on 01-jan-2018 [ "arg2 under the brand name arg1" "arg2 to lower the price of arg1" ] using (zerit, bristol_myers_squibb)
• SEAL @263 (93.8%) on 22-may-2011 [ 1 2 3 4 ] using (zerit, bristol_myers_squibb)
• competeswith
• pfizer
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (bristol_myers_squibb, pfizer)
• CPL @1115 (50.0%) on 27-aug-2018 [ "arg1 Co and arg2" ] using (pfizer, bristol_myers_squibb)